Syntrix's dual CXCR1/CXCR2 inhibitor for combos in oral, lung cancers

DISEASE CATEGORY: Cancer

INDICATION: Lung cancer; solid tumors

Mouse studies suggest combining the dual CXCR1/CXCR2 inhibitor SX-682 with anti-PD-1

Read the full 179 word article

User Sign In